SUBSCRIBE
SUBSCRIBE
News   Policy

Group Wants FDA To Review More Drug Ads

December 14, 2006 | 
1 min read

WASHINGTON - Regulators are issuing fewer citations to drug companies for false and misleading advertisements and are taking longer to do it, a congressional report says. >>> Discuss This Story

Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
A cartoon of a scientist standing in a laboratory, next to a microscope and flasks
Government
100+ CEOs, Biopharma Leaders Sound Alarm on ‘Catastrophic’ Health Cuts
June 30, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA
FDA’s AI Rollout Raises Questions Around Readiness, Legality
June 30, 2025
 · 
6 min read
 · 
Natalia Mesa
Facade of the FDA's office in Maryland
Approvals
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
June 30, 2025
 · 
9 min read
 · 
Tristan Manalac
Themis with sword and scales in cyberspace. Ai regulation, artificial intelligence and law issues concept. Vector illustration.
Legal
Supreme Court Leaves PrEP Drug Coverage Decisions to RFK’s Task Force
June 27, 2025
 · 
2 min read
 · 
Annalee Armstrong